Karabulut B - Search Results

1

Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancer.

Kucukzeybek Y, Gorumlu G, Karaca B, Erten C, Cengiz E, Kemal Gul M, Karabulut B, Uslu R, Sanli UA, Goker E. Kucukzeybek Y, et al. Among authors: karabulut b. J BUON. 2008 Apr-Jun;13(2):199-203. J BUON. 2008. PMID: 18555465

2

Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines.

Uslu R, Sanli UA, Sezgin C, Karabulut B, Terzioglu E, Omay SB, Goker E. Uslu R, et al. Among authors: karabulut b. Clin Cancer Res. 2000 Dec;6(12):4957-64. Clin Cancer Res. 2000. PMID: 11156257

3

Which dosing scheme is suitable for the taxanes? An in vitro model.

Sanli UA, Uslu R, Karabulut B, Sezgin C, Saydam G, Omay SB, Goker E. Sanli UA, et al. Among authors: karabulut b. Arch Pharm Res. 2002 Aug;25(4):550-5. doi: 10.1007/BF02976617. Arch Pharm Res. 2002. PMID: 12214871

4

Alterations in the activity and expression of serine/threonine protein phosphatases during all trans retinoic acid-induced apoptosis in breast cancer cells.

Sanli UA, Uslu R, Karabulut B, Sezgin C, Selvi N, Aydin HH, Saydam G, Goker E, Omay SB. Sanli UA, et al. Among authors: karabulut b. Oncol Rep. 2003 Nov-Dec;10(6):2083-8. Oncol Rep. 2003. PMID: 14534748

5

Differential effects of doxorubicin and docetaxel on nitric oxide production and inducible nitric oxide synthase expression in MCF-7 human breast cancer cells.

Oktem G, Karabulut B, Selvi N, Sezgin C, Sanli UA, Uslu R, Yurtseven ME, Omay SB. Oktem G, et al. Among authors: karabulut b. Oncol Res. 2004;14(7-8):381-6. doi: 10.3727/0965040041292305. Oncol Res. 2004. PMID: 15301429

6

Bioembolisation for unresectable hepatocellular carcinoma: preliminary results of a translational research study.

Goker E, Sanli UA, Yuzer Y, Uslu R, Karabulut B, Memis A, Coker A, Mentes A. Goker E, et al. Among authors: karabulut b. J Exp Clin Cancer Res. 2004 Sep;23(3):403-9. J Exp Clin Cancer Res. 2004. PMID: 15595628 Clinical Trial.

7

Preparation of arsenic trioxide-loaded microemulsion and its enhanced cytotoxicity on MCF-7 breast carcinoma cell line.

Karasulu HY, Karabulut B, Kantarci G, Ozgüney I, Sezgin C, Sanli UA, Göker E. Karasulu HY, et al. Among authors: karabulut b. Drug Deliv. 2004 Nov-Dec;11(6):345-50. doi: 10.1080/10717540490494096. Drug Deliv. 2004. PMID: 15736829 Free article.

8

Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens.

Uslu R, Sanli UA, Dikmen Y, Karabulut B, Ozsaran A, Sezgin C, Muezzinoglu GG, Omay SB, Goker E. Uslu R, et al. Among authors: karabulut b. Int J Gynecol Cancer. 2005 Mar-Apr;15(2):240-5. doi: 10.1111/j.1525-1438.2005.15210.x. Int J Gynecol Cancer. 2005. PMID: 15823106 Free article. Clinical Trial.

9

Potential predictive factors for response to weekly paclitaxel treatment in patients with metastatic breast cancer.

Sezgin C, Karabulut B, Uslu R, Sanli UA, Goksel G, Zekioglu O, Ozdemir N, Goker E. Sezgin C, et al. Among authors: karabulut b. J Chemother. 2005 Feb;17(1):96-103. doi: 10.1179/joc.2005.17.1.96. J Chemother. 2005. PMID: 15828451

10

Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma.

Kurt E, Sezgin C, Evrensel T, Yalcinkaya U, Kanat O, Veral A, Demiray M, Arslan M, Karabulut B, Ercan I, Goker E, Manavoglu O. Kurt E, et al. Among authors: karabulut b. Int J Clin Pract. 2005 May;59(5):537-43. doi: 10.1111/j.1368-5031.2005.00447.x. Int J Clin Pract. 2005. PMID: 15857349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters